Evolutionary Genomics, Inc. announced that it has received $0.49 million in funding
May 15, 2019
Share
Evolutionary Genomics, Inc. (OTCPK:FNAM) announced that it has received $490,000 in funding from four investors on May 15, 2019. The company issued common stock in the transaction. The company issued securities pursuant to exemption provided under Regulation D. The company is expecting to receive $1,050,000 in funding from the transaction.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
EVOLUTIONARY GENOMICS, INC. 
